Noseworthy Kate, Silburt Joseph, Hynynen Kullervo, Aubert Isabelle
Hurvitz Brain Sciences Research Program, Biological Sciences, Sunnybrook Research Institute, Toronto, ON, Canada.
Department of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
bioRxiv. 2025 May 22:2025.05.21.655298. doi: 10.1101/2025.05.21.655298.
The current study aims to fill a gap in knowledge on the effects of focused ultrasound (FUS)-mediated blood-brain-barrier (BBB) modulation on the proliferation and development of oligodendrocyte progenitor cells (OPCs). Researchers established that FUS combined with intravenous microbubbles can modulate the BBB in a controlled, reversible, localized, and non-invasive manner to facilitate the delivery of intravenous therapeutics to the brain. Over a decade ago, we discovered that, even without intravenous therapeutics, FUS-BBB modulation stimulates elements of brain repair, including hippocampal neurogenesis.
In adult mice, FUS-BBB modulation was targeted unilaterally to the hippocampus and proliferation of OPCs was quantified at 1, 4, 7, and 10 days post-FUS. Mature oligodendrocytes were quantified at 30 days post-FUS. OPC proliferation was assessed at 7 days post-FUS, and mature oligodendrocytes at 30 days.
The proliferation of hippocampal OPCs was increased by 6.8-fold and 2.3-fold between 1 and 4 days post-sonication, respectively, resulting in a 5.3-fold increase in mature oligodendrocytes one month later. To test the robustness of oligodendrogenesis following FUS-BBB modulation, the striatum was targeted as a second brain region with an independent experimental design. In line with hippocampal results, striatal FUS-BBB modulation promoted the generation of OPCs by 3.9-fold during the first week, leading to a 5.2-fold increase in oligodendrogenesis 30 days post-treatment.
We conclude that FUS-BBB modulation in the hippocampus and striatum promotes oligodendrogenesis by stimulating the proliferation of OPCs and being permissive to their maturation.
本研究旨在填补聚焦超声(FUS)介导的血脑屏障(BBB)调节对少突胶质前体细胞(OPCs)增殖和发育影响方面的知识空白。研究人员证实,FUS联合静脉注射微泡能够以可控、可逆、局部且无创的方式调节血脑屏障,以促进静脉治疗药物向脑内的递送。十多年前,我们发现,即使没有静脉治疗药物,FUS-BBB调节也能刺激脑修复的相关因素,包括海马神经发生。
在成年小鼠中,将FUS-BBB调节单侧靶向至海马体,并在FUS后1、4、7和10天对OPCs的增殖进行定量。在FUS后30天对成熟少突胶质细胞进行定量。在FUS后7天评估OPCs增殖,30天评估成熟少突胶质细胞。
在超声处理后1至4天之间,海马体OPCs的增殖分别增加了6.8倍和2.3倍,一个月后成熟少突胶质细胞增加了5.3倍。为了测试FUS-BBB调节后少突胶质生成的稳健性,将纹状体作为第二个脑区进行独立实验设计。与海马体的结果一致,纹状体FUS-BBB调节在第一周促进OPCs生成增加3.9倍,导致治疗后30天少突胶质生成增加5.2倍。
我们得出结论,海马体和纹状体中的FUS-BBB调节通过刺激OPCs的增殖并促进其成熟来促进少突胶质生成。